Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
Nanoparticles prepared by self-assembly from oligonucleotides (ONs), protamine free base, and human serum albumin ("ternary proticles") are spheres of diameters around 200 nm. Substitution of the protamine free base by protamine sulfate leads to proticles of only around 40 nm in diameter with otherwise unchanged properties. The availability of drug delivery systems of very similar composition but grossly different size may be advantageous when dealing with cells which show size-dependent particle uptake. These nanoparticles are promising candidates for ON delivery to cells because of the following reasons: (1) They are stable for several hours in solutions of up to physiological ionic strength; (2) they are efficiently taken up by cells; (3) after cellular uptake, they easily release the ONs even when these are present as phosphorothioates.
Mayer
Gottfried
G
Institut für Biophysik, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, Haus 74, 60590 Frankfurt am Main, Germany.
Vogel
Vitali
V
Weyermann
Jörg
J
Lochmann
Dirk
D
van den Broek
Jacomina A
JA
Tziatzios
Christos
C
Haase
Winfried
W
Wouters
Daan
D
Schubert
Ulrich S
US
Zimmer
Andreas
A
Kreuter
Jörg
J
Schubert
Dieter
D
D000818:Animals; D002478:Cells, Cultured; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D005347:Fibroblasts; D016650:Fluorescein-5-isothiocyanate; D005456:Fluorescent Dyes; D051379:Mice; D018625:Microscopy, Atomic Force; D046529:Microscopy, Electron, Transmission; D049329:Nanostructures; D009841:Oligonucleotides / Q000737:chemistry* / Q000378:metabolism; D011479:Protamines / Q000737:chemistry* / Q000378:metabolism; D012709:Serum Albumin / Q000737:chemistry* / Q000378:metabolism; D013873:Thionucleotides / Q000737:chemistry* / Q000378:metabolism
D004337:Drug Carriers; D005456:Fluorescent Dyes; D009841:Oligonucleotides; D011479:Protamines; D012709:Serum Albumin; D013873:Thionucleotides; D016650:Fluorescein-5-isothiocyanate